Search for: "Eli Lilly " Results 1781 - 1800 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Dec 2008, 9:48 am
 Durch die Entscheidung  wurde ein Patent des Unternehmens Eli Lilly and Co Ltd., welches den pharmazeutischen Wirkstoff “Olanzapin” betrifft, für nichtig erklärt. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic medicine… [read post]
5 Dec 2008, 3:57 pm
Marketed as Cialis by Eli Lilly, Tadalafil is one of the drug that was granted exclusive marketing right (EMR) in India against the application # 85/DEL/1995 (the 1995 application) which later got stayed by the Calcutta High Court after a petition made by Mumbai-based Ajanta Pharma. [read post]
29 Nov 2008, 6:16 pm by Anthony Fazzio
Read: Jeffrey Young, The Hill, 9-24-08, Eli Lilly to disclose financial ties to doctors [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
26 Nov 2008, 5:39 pm
Sidley and Pepper Hamilton have advised Eli Lilly & Co. in entering into settlements with both federal and state prosecutors that will eventually top $2 billion, mostly over the fraudulent marking of the antipsychotic drug Zyprexa. [read post]
25 Nov 2008, 6:00 pm
In September I applauded Eli Lilly for beginning “voluntary” disclosures of physician funding for research. http://www.shragerlaw.com/blog/? [read post]
22 Nov 2008, 12:06 pm
Lately Kolkata Patent Office issued an Indian Patent No. 225209 to Eli Lilly & Co. for crystalline non-solvated anhydrous Arzoxifene. [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings) (Hal… [read post]
19 Nov 2008, 1:16 pm
This particular drug is injected, which means that its cost to patients and our healthcare system are much greater – which also increases the incentive for aggressive marketing by the manufacturers, Eli Lilly and Amylin. [read post]
18 Nov 2008, 10:40 pm
Wockhardt is lately been sued by Eli Lilly & Co. for alleged infringement of OB listed patent for antidepressant drug Cymbalta, generically Duloxetine. [read post]
14 Nov 2008, 5:54 am
In the paper, entitled "The Changing Legal Landscape For Intellectual Property," former Attorney General and Pennsylvania Governor Dick Thornburgh (Of Counsel at K&L Gates LLP), moderates a discussion on the role that intellectual property protection plays in commerce and innovation with Robert Armitage, Senior Vice President and General Counsel of Eli Lilly and Company; Michael Fricklas, Executive Vice President, General Counsel,... [read post]
6 Nov 2008, 3:08 am
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
6 Nov 2008, 1:00 am
Rock star GCs from Intel, Eli Lilly, Cisco and Tessera talked about patent reform and patent trolls today, and it got briefly uncomfortable. [read post]
2 Nov 2008, 3:38 pm
The following timeline might be of assistance in gathering our thoughts about Byetta and its manufacturers, Amylin and Eli Lilly: April 2005 – Byetta gains FDA Approval: Prior to obtaining FDA approval to market Byetta in April 2005, Amylin/Lilly had conducted three double-blind, placebo-controlled safety and efficacy clinical trials, which enrolled a combined 1446 subjects with Type 2 diabetes. [read post]
31 Oct 2008, 3:17 pm
My law firm currently represents victims and their families in lawsuits against most of the major drug companies including Merck, Pfizer, Bayer, Eli Lilly and others. [read post]
30 Oct 2008, 11:34 am
It is a twice daily injection which is sold in a pre-filled pen by Amylin Pharmaceuticals and Eli Lilly & Co. [read post]
25 Oct 2008, 12:15 pm
Karen Horn, a director since September 2006, also sits on the boards of Eli Lilly and Company, Simon Property Group, all T. [read post]